Hepatología: Metabolismo, Epigenética y Carcinogénesis
METACAN
Clínica Universitaria de Navarra
Pamplona, EspañaClínica Universitaria de Navarra -ko ikertzaileekin lankidetzan egindako argitalpenak (41)
2024
-
Caspases compromise SLU7 and UPF1 stability and NMD activity during hepatocarcinogenesis
JHEP Reports, Vol. 6, Núm. 8
-
Comprehensive in silico CpG methylation analysis in hepatocellular carcinoma identifies tissue- and tumor-type specific marks disconnected from gene expression
Journal of Physiology and Biochemistry
-
Identification of PRMT5 as a therapeutic target in cholangiocarcinoma
Gut
-
New insights into the regulation of bile acids synthesis during the early stages of liver regeneration: A human and experimental study
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1870, Núm. 5
2023
-
Comprehensive analysis of epigenetic and epitranscriptomic genes’ expression in human NAFLD
Journal of Physiology and Biochemistry, Vol. 79, Núm. 4, pp. 901-924
-
Identification and experimental validation of druggable epigenetic targets in hepatoblastoma
Journal of Hepatology, Vol. 79, Núm. 4, pp. 989-1005
2022
-
DNA Methylation Regulates a Set of Long Non-Coding RNAs Compromising Hepatic Identity during Hepatocarcinogenesis
Cancers, Vol. 14, Núm. 9
-
Next-generation sequencing of bile cell-free DNA for the early detection of patients with malignant biliary strictures
Gut, Vol. 71, Núm. 6, pp. 1141-1151
2021
-
Dual Targeting of G9a and DNA Methyltransferase-1 for the Treatment of Experimental Cholangiocarcinoma
Hepatology, Vol. 73, Núm. 6, pp. 2380-2396
-
The splicing regulator SLU7 is required to preserve DNMT1 protein stability and DNA methylation
Nucleic Acids Research, Vol. 49, Núm. 15, pp. 8592-8609
2019
-
Splicing events in the control of genome integrity: Role of SLU7 and truncated SRSF3 proteins
Nucleic Acids Research, Vol. 47, Núm. 7, pp. 3450-3466
-
The Epidermal Growth Factor Receptor Ligand Amphiregulin Protects From Cholestatic Liver Injury and Regulates Bile Acids Synthesis
Hepatology, Vol. 69, Núm. 4, pp. 1632-1647
2018
-
An Inducible Promoter Responsive to Different Porphyrinogenic Stimuli Improves Gene Therapy Vectors for Acute Intermittent Porphyria
Human Gene Therapy, Vol. 29, Núm. 4, pp. 480-491
-
Systemic messenger RNA as an etiological treatment for acute intermittent porphyria
Nature Medicine, Vol. 24, Núm. 12, pp. 1899-1909
2017
-
X-box Binding Protein 1 Regulates Unfolded Protein, Acute-Phase, and DNA Damage Responses During Regeneration of Mouse Liver
Gastroenterology, Vol. 152, Núm. 5, pp. 1203-1216.e15
2016
-
Chromatin Remodeling and Epigenetic Reprogramming in Chronic Disease and Cancer in the Liver and Pancreas
Chromatin Signaling and Diseases (Elsevier Inc.), pp. 365-385
-
Emerging therapies for acute intermittent porphyria
Expert Reviews in Molecular Medicine, Vol. 18
-
Glucose metabolism during fasting is altered in experimental porphobilinogen deaminase deficiency
Human Molecular Genetics, Vol. 25, Núm. 7, pp. 1318-1327
-
New molecular interactions of c-Myc in cholangiocarcinoma may open new therapeutic opportunities
Hepatology
2015
-
Helper-dependent adenovirus achieve more efficient and persistent liver transgene expression in non-human primates under immunosuppression
Gene Therapy, Vol. 22, Núm. 11, pp. 856-865